US industry takes stock after WTO talks fail in Seattle
This article was originally published in Clinica
The US medical device industry is planning to wait several months before resuming lobbying activities for its worldwide trade agenda, following the collapse of the World Trade Organization (WTO) ministerial meeting in Seattle.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.